Quantamatrix

Multiplexed platform for disease daignosis

placeSeoul, Seoul, South Korea calendar_todayFounded 2010 groups113 employees language quantamatrix.com

Innovation

23 patent families (16 granted) — focus: Chemistry & metallurgy, Operations & transport, Physics & computing; filing pace slowing. Cited 608 times.

YearFilings
20131
20151
20172
20184
20194
20208
20217
20227
20236
20245
20255

Social engagement

Social engagement: 2.7K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Treatment Action Group.

Investor typeCountShare
Venture capital563%
Private equity113%
Accelerator & incubator113%
Other / undisclosed113%

Recent activity

1 Jul 2026
Event
ACMTT Day 2 Luncheon Session on Transforming the Future Landscape of Bacteremia Diagnosis and Therapy: dRAST, uCIA and workflow innovation
24 Jun 2026
Event
ACMTT 2026
19 Apr 2026
Event
ESCMID global 2026
Coming soon